top of page


August 2, 2022

XMS Advised Exact Sciences on the Sale of its Oncotype DX® GPS Prostate Cancer Business to Mdxhealth

MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the "Company"), a commercial-stage precision diagnostics company, today announced it has entered into an asset purchase agreement with Genomic Health, Inc., a subsidiary of Exact Sciences Corporation ("Exact Sciences"), to acquire the Oncotype DX® GPS (Genomic Prostate Score®) test from Exact Sciences along with most of its team of urology sales and marketing professionals.

July 19, 2022

XMS Advised Unity Aluminum on its Joint Venture Arrangement with Steel Dynamics

Steel Dynamics, Inc. (NASDAQ/GS: STLD) today announced that its Board of Directors has authorized the company to construct and operate a 650,000-tonne low-carbon, recycled aluminum flat rolled mill, with two supporting satellite recycled aluminum slab centers. The capital investment is estimated to be $2.2 billion for the three facilities, and commercial production is planned to begin in the first quarter 2025.

Read More

Jul 5, 2022

XMS Advised Aon on the Sale of its eDiscovery Practice to TCDI

TCDI, a leading provider of legal services, software and cybersecurity, today announced it completed the acquisition of global professional services firm Aon’s eDiscovery practice.

Jan 20, 2022

Core Scientific to Begin Trading on Nasdaq

Core Scientific, Inc. common stock and warrants to begin trading on the Nasdaq Stock Market under symbols “CORZ” and “CORZW” on January 20, 2022

Jan 09, 2022

Exact Sciences Acquires PreventionGenetics To Accelerate Availability Of Hereditary Cancer Testing For More Patients

PreventionGenetics' comprehensive genetic testing portfolio complements Exact Sciences' advanced cancer tests, enabling disease prevention and earlier cancer detection to benefit patients across decades of life. Foundational laboratory and skilled team with experience in sequencing, informatics, and genetic counseling will support entrance into hereditary cancer testing

Dec 01, 2021


Riot’s position as a vertically-integrated industry leader in Bitcoin mining significantly enhanced via the acquisition of ESS Metron, a premier provider of highly-engineered electrical equipment solutions

Oct 26, 2021

XMS Serves as Financial Advisor to IAA on its acquisition of SYNETIQ

XMS Capital Partners, LLC (“XMS”), a global, independent financial services firm providing investment banking, asset management and merchant banking services, announced that it served as financial advisor to IAA, Inc. (NYSE: IAA), a leading global digital marketplace connecting vehicle buyers and sellers, on its acquisition of SYNETIQ Ltd. (“SYNETIQ”), a leading integrated salvage and vehicle dismantling company in the United Kingdom, for £225 million.

Sept 23, 2021

Argo Blockchain PLC

Argo Blockchain, a global leader in cryptocurrency mining (LSE: ARB), is pleased to announce the pricing of its initial public offering.

Jun 07, 2021

Vintage Wine Estates and Bespoke Capital Acquisition Corp. Announce Closing of Business Combination

Common Stock to Commence Trading on the Nasdaq Global Market Under New Symbol “VWE” on June 8

Apr 8, 2021

Riot Blockchain in its acquisition of Whinstone US, Inc.

Combination of leading US-based Bitcoin miner with owner and operator of America’s largest Bitcoin hosting facility will create leading US-based corporate pillar in support of the Bitcoin mining network

Mar 22, 2021

XMS Serves as Financial Advisor to BioLife Solutions on its acquisition of Stirling Ultracold

XMS Capital Partners, LLC (“XMS”), a global, independent financial services firm providing investment banking, asset management and merchant banking services, announced that it served as financial advisor to BioLife Solutions, Inc. (NASDAQ: BLFS), on its acquisition of Global Cooling, Inc., operating as Stirling Ultracold ("Stirling"), a privately held manufacturer of ultra-low temperature ("ULT") mechanical freezers.

Jan 13, 2021

Exact Sciences Licenses Targeted Digital Sequencing Method To Extend Leadership In Precision Oncology

Worldwide Exclusive License Provides Access to Targeted Digital Sequencing (TARDIS) Blood Biopsy Method for Use in Minimal Residual Disease Testing

bottom of page